MTVA MetaVia Inc.
$1.66▼ -5.14%
Healthcare
Other
After hours
$1.74▲ +4.82%
Sep 11, 7:30 PM ET
Volume 56.8K
Avg Volume (10D) 117.0K
Key Metrics & Fundamentals
Market Cap
$10.94M
P/E Ratio
–
Div Yield
–%
52W Range
0.97 - 19.03
% vs 50 MA
3.98%
% vs 200 MA
-42.84%
RSI-14
51.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.69
Free Cash Flow
-$3.76M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.38M
COGS
–
Operating Exp
$5.39M
Operating Income
-$5.39M
EBIT
-$5.39M
Pretax Income
-$5.32M
Net Income
-$5.32M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
MTVA: Preclinical Findings Support DA-1726 Waist Circumference Reduction
Zacks Small Cap Research · Sep 10, 2026 12:25 PM
MetaVia Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction
PR Newswire · Sep 9, 2026 12:00 PM
MTVA: Dose Titration Complete in Phase 1 Part 3 Study of DA-1726
Zacks Small Cap Research · Aug 12, 2026 12:20 PM
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
PR Newswire · Aug 6, 2026 8:05 PM
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Jul 9, 2026 7:49 PM
Sector Update: Healthcare Stocks Decline in Afternoon Trading
MT Newswires · Jul 9, 2026 5:46 PM
MetaVia Says Patients on Experimental Obesity Drug Reach Highest Target Doses in Phase 1 Trial
MT Newswires · Jul 9, 2026 12:58 PM
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
PR Newswire · Jul 9, 2026 12:31 PM
OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz
Zacks Small Cap Research · Jun 30, 2026 2:42 PM
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
GlobeNewswire · Jun 26, 2026 12:35 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See MTVA's money flow as a full page
Social Sentiment
No Reddit posts found for MTVA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.